LMAT

108.06

1.43% 1.52

Dopo l'orario di chiusura: 108.06

Lemaitre Vascular Inc (LMAT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Storia dei dividendi

Precedente Chiudi:

$106.54

Aprire:

$107.7

Volume 24 ore:

156.44K

Relative Volume:

0.85

Capitalizzazione di mercato:

$2.46B

Reddito:

$249.60M

Utile/perdita netta:

$57.73M

Rapporto P/E:

42.99

EPS:

2.5139

Flusso di cassa netto:

$74.47M

1 W Prestazione:

+0.62%

1M Prestazione:

+23.27%

6M Prestazione:

+17.09%

1 anno Prestazione:

+37.10%

Intervallo 1D:

$106.57

$108.74

Intervallo di 1 settimana:

$105.20

$112.00

Portata 52W:

$71.42

$115.33

Lemaitre Vascular Inc Stock (LMAT) Company Profile

Nome

Lemaitre Vascular Inc

Settore

Healthcare (1116)

Industria

Medical Instruments & Supplies (58)

Telefono

781-221-2266

Indirizzo

63 SECOND AVENUE, BURLINGTON, MA

Dipendente

655

Cinguettio

@LMAT_Vascular

Prossima data di guadagno

2025-02-24

Ultimi documenti SEC

LMAT's Discussions on Twitter

Compare LMAT vs ISRG, BDX, ALC, MDLN, RMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LMAT Lemaitre Vascular Inc	108.06	2.46B	249.60M	57.73M	74.47M	2.5139
ISRG Intuitive Surgical Inc	472.16	167.68B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	159.36	45.33B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	77.32	37.69B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	41.46	33.65B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	230.84	33.63B	5.40B	1.49B	1.78B	10.12

Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-08-06	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2025-02-28	Downgrade	Barrington Research	Outperform → Mkt Perform
2025-02-28	Downgrade	Oppenheimer	Outperform → Perform
2025-02-13	Iniziato	Wells Fargo	Equal Weight
2024-10-15	Iniziato	Cantor Fitzgerald	Neutral
2024-08-02	Ripresa	Lake Street	Buy
2024-05-31	Ripresa	ROTH MKM	Buy
2024-04-26	Aggiornamento	Stifel	Hold → Buy
2024-02-06	Ripresa	KeyBanc Capital Markets	Sector Weight
2023-10-23	Iniziato	JMP Securities	Mkt Outperform
2023-09-06	Iniziato	Oppenheimer	Outperform
2023-08-03	Downgrade	Jefferies	Buy → Hold
2023-05-03	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2022-10-28	Downgrade	Barrington Research	Outperform → Mkt Perform
2021-09-16	Iniziato	Jefferies	Buy
2021-02-12	Iniziato	KeyBanc Capital Markets	Sector Weight
2020-03-16	Aggiornamento	Sidoti	Neutral → Buy
2019-10-24	Downgrade	First Analysis Sec	Strong Buy → Outperform
2019-10-24	Aggiornamento	Lake Street	Hold → Buy
2019-10-14	Aggiornamento	First Analysis Sec	Outperform → Strong Buy
2019-07-25	Reiterato	Barrington Research	Outperform
2019-07-25	Aggiornamento	First Analysis Sec	Neutral → Outperform
2018-10-08	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2018-10-08	Aggiornamento	ROTH Capital	Neutral → Buy
2018-06-08	Ripresa	ROTH Capital	Buy
2018-04-26	Downgrade	Stifel	Buy → Hold
2018-04-26	Aggiornamento	The Benchmark Company	Hold → Buy
2017-10-27	Downgrade	First Analysis Sec	Overweight → Equal-Weight
2017-10-27	Downgrade	The Benchmark Company	Buy → Hold
2017-07-10	Downgrade	Canaccord Genuity	Buy → Hold
2017-07-10	Downgrade	The Benchmark Company	Buy → Hold
2017-03-21	Iniziato	First Analysis Sec	Overweight
2017-02-22	Downgrade	Barrington Research	Outperform → Mkt Perform
2016-09-22	Downgrade	Sidoti	Buy → Neutral
2016-07-28	Reiterato	Barrington Research	Outperform
2016-02-25	Reiterato	Barrington Research	Outperform

Mostra tutto

Lemaitre Vascular Inc Borsa (LMAT) Ultime notizie

Mar 13, 2026

Insider Sell: David Roberts Sells Shares of LeMaitre Vascular In - GuruFocus

Mar 13, 2026

LeMaitre Vascular (LMAT) president sells 3,311.68 shares in open market trade - Stock Titan

Mar 13, 2026

Kennedy Capital Management LLC Has $18.89 Million Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat

Mar 13, 2026

3 Healthcare Stocks to Avoid in 2026: Analysis of UnderperformersNews and Statistics - IndexBox

Mar 13, 2026

Mar 11, 2026

LMAT (NASDAQ) Form 144: Trent Kamke plans sale of 2,625 shares via option exercise - Stock Titan

Mar 11, 2026

Mar 10, 2026

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Announces Quarterly Dividend of $0.25 - MarketBeat

Mar 10, 2026

First Trust Advisors LP Grows Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat

Mar 10, 2026

Stronger 2025 Results, Higher Dividend and Buyback Might Change The Case For Investing In LeMaitre Vascular (LMAT) - simplywall.st

Mar 10, 2026

Mar 08, 2026

Avoiding Lag: Real-Time Signals in (LMAT) Movement - Stock Traders Daily

Mar 08, 2026

LeMaitre Vascular Stock Forms Golden Cross, Signals Bullish Breakout Ahead - Markets Mojo

Mar 08, 2026

Mar 07, 2026

LeMaitre Vascular Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics - Markets Mojo

Mar 07, 2026

Is LeMaitre Vascular Inc. stock a safe haven assetTrade Exit Summary & Verified Momentum Watchlists - Naître et grandir

Mar 07, 2026

Mar 06, 2026

Is LeMaitre Vascular Inc stock showing strong momentumMarket Trend Review & Low Risk Entry Point Guides - baoquankhu1.vn

Mar 06, 2026

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of "Hold" from Analysts - MarketBeat

Mar 04, 2026

Mar 03, 2026

LeMaitre Vascular Experiences Revision in Stock Evaluation Amid Strong Performance Metrics - Markets Mojo

Mar 03, 2026

LeMaitre Vascular Hits New 52-Week High at $115.33, Up 46.41% - Markets Mojo

Mar 03, 2026

LMAT SEC FilingsLemaitre Vasculr 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 03, 2026